Sponsor hub

University of Colorado, Denver clinical trial failures

Review 70 stopped clinical trials from University of Colorado, Denver, including disease areas, phases, and classified stop reasons.

This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 0 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.

Total stopped trials70
Likely biological signals0
Shown below70

Dominant stop reasons

OPERATIONAL
43
OTHER/UNKNOWN
26
REGULATORY
1

Notable sponsors

University of Colorado, Denver
70

Related phases

Phase II
24
Phase IV
13
Phase I
12
Unknown
12
Phase III
6

Crawlable stopped-trial records

Open Explore

Showing up to 70 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.

NCT03720483: Inhaled NAC in Treatment of IPF

Phase I Idiopathic Pulmonary Fibrosis (IPF) trial by University of Colorado, Denver. Stop reason: OPERATIONAL.

The study encountered challenges during startup due to the COVID-19 epidemic and was withdrawn.